Amedisys Overview
Amedisys Target Price
Analysts' 12-month price predictions for AMED.
Get informed when a big investor buys or sells
+ FollowShare Price
$100.99
Average Target Price
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2024-03-25 | RBC CapitalFrank Morgan | $100 |  1% downside |  |
| 2023-07-06 | JefferiesBrian Tanquilut | $90.8 | 10.1% downside | |
| 2023-01-05 | Leerink Partners | $85 | 15.8% downside | |
| 2022-11-11 | Stephens | $106 |  5% upside | |
| 2022-07-26 | Truist FinancialDavid MacDonald | $150 | 48.5% upside | |
| 2022-07-03 | Deutsche BankJustin Bowers | $175 | 73.3% upside | |
| 2022-04-29 | Credit Suisse | $182 | 80.2% upside | |
| 2022-04-29 | Raymond James | $180 | 78.2% upside | |
| 2022-04-29 | Leerink Partners | $131 | 29.7% upside | |
| 2022-02-25 | BMO CapitalMatthew Borsch | $190 | 88.1% upside | |
| 2022-02-25 | RBC CapitalBen Hendrix | $199 | 97% upside | |
| 2022-02-24 | Deutsche BankJustin Bowers | $230 | 127.7% upside | |
| 2022-02-24 | Benchmark Co.Bill Sutherland | $175 | 73.3% upside | |
| 2021-11-04 | StephensScott Fidel | $185 | 83.2% upside | |